Choose a country to view content specific to your location
Choose a country to view content specific to your location
肿瘤分子检测在癌症诊断、预后、治疗决策和监测中发挥着至关重要的作用。传统的分子检测主要采用组织活检，而当今技术的进步使分子检测可以使用侵入性较小的体液进行液体活检，更扩大了检测的可及性。
Meridian迈迪安生物科技是开发 qPCR和等温扩增分子检测的领先上游原料企业，为检测癌症相关的基因突变，包括单核苷酸多态性 (SNP)的商业检测提供创新型的分子试剂。
其中，Lyo-Ready可冻干基因分型qPCR直扩预混液在这方面检测上尤其具有显著的优势，主要包括简化开发和操作流程、提供卓越的聚类分辨率和等位基因鉴别能力，以及可兼容冻干技术。
本次线上直播中，您将了解到：
1. 从高通量到POC平台，加快基因分型检测的最新技术发展
2. 迈迪安最先进的SNP qPCR配方，直接从血液、血浆、尿液、粪便或 FFPE 组织中超灵敏检测 SNP（低至 1 个拷贝/反应），无需提取核酸
3. 通过这些SNP检测帮助预测癌症风险和对某些药物的反应
主讲嘉宾:
Alpha Chen ，迈迪安生物科技市场&分子产品技术
Steve Hawkins， 迈迪安生物科技分子产品经理
Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 diseases and an extensive range of specialty qPCR/RT-qPCR master mixes and molecular enzymes all manufactured under ISO13485 regulations.
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
